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The patient is a 78 year-old male with
a past medical history of
hypertension and duodenal ulcer
presenting with 2 months of
increasing abdominal girth. The
patient reports 1 month of loose
bowel movements and a 2 week
history of early satiety. He notes that
in the last week he has been nauseous
at the smell and thought of food. He
denies fevers, chills, excessive alcohol
intake, history of blood transfusions,
intravenous drug use, melena or
bright red blood per rectum. The
patient states he has never undergone
a colonoscopy and to his knowledge
there is no family history of
malignancy.
The patient was admitted to the
hospital and a diagnostic study was
performed. The images from a CT
scan demonstrate multiple loculated
fluid collections with enhancing
walls within the peritoneal cavity.
The largest mass was located
anteriorly within the peritoneal
cavity and measured 30cm x 14 cm
(transverse x AP) and extended from
the liver to the bladder. These
finding were consistent with a
pseudomyxoma peritonei and the
patient was taken to surgery for an exploratory
laparotomy. The patient underwent an evacuation of the
gelatinous tumor and an ileocecal resection with
primary ileoascending colostomy. The pathology report
revealed the origin of the mucinous secretions was in
fact an appendiceal cystadenocarcinoma.
Pseudomyxoma peritonei is a rare condition resulting
from rupture of a mucocele of the appendix, a mucinous
ovarian cyst, or mucin-secreting intestinal or ovarian
adenocarcinoma. It is two to three times more common
in females than in males. It is often an unexpected
finding during a laparotomy and is said to be found in 2
of every 10,000 laparotomies.
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The primary treatment remains
surgical debulking although the rate of
recurrence in the twelve-year Mayo
Clinic series was 76% with 50% of
recurrences in the first 2.5 years. It is
not clear if adjuvant radiotherapy
and/or chemotherapy is beneficial.
The five-year survival rate ranges from
53 to 75%, but outcomes vary widely
between relatively benign and
malignant subgroups. Patients with
appendiceal
cystadenocarcinomas
with pseudomyxoma peritonei have a
25% five-year survival rate, with most
deaths attributed to intestinal
obstruction or renal failure. The study
of pseudomyxoma peritonei is limited
by the rarity of the condition and the
small number of cases collected in
published series.
References
1. Landen S, Bertrand C, Maddern GJ,
et al. Appendiceal mucoceles and
pseudomyxoma peritonei. Surg
Gynecol Obstet 1992; 175:401.
2. Gough DB, Donohue JH, Schutt AJ,
Gonchoroff N, Goellner JR, Wilson
TO et al. Pseudomyxoma peritonei.
Long-term patient survival with an
aggressive regional approach. Ann
Surg 1994; 219: 112-19.
3. Mann WJ Jr, Wagner J, Chumas J, Chalas E. The
management of pseudomyxoma peritonei. Cancer 1990;
66: 1636-40.
4. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young
RH. Appendiceal Mucinous Neoplasms: A clinicopathologic analysis of 107 Cases. American Journal of
Surgical Pathology 2003; 27(8):1089-1103.
5. Esquivel J, Sugarbaker PH. Clinical presentation of the
pseudomyxoma peritonei syndrome. British Journal of
Surgery 2000; 87(10):1414-1418.
6. Sugarbaker, PH Shmookler, B.; Ronnett, B. M. Chang, D.
Pseudomyxoma peritonei. British Journal of Surgery 1999;
86(6):842.

